2024 annual financial data
ADMA Biologics 2024 Operating margin
ADMA Biologics 2024 operating margin with verified reported values.
Direct answer
Operating margin was 32.59%.
Operating income was 138,983,000 USD and net income was 197,673,000 USD.
Operating cash flow was 118,672,000 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 426,454,000 USD
- Operating income
- 138,983,000 USD
- Net income
- 197,673,000 USD
- Operating cash flow
- 118,672,000 USD